Download PDF
Hamostaseologie 1985; 05(02): 44-53
DOI: 10.1055/s-0038-1655100
Originalarbeiten
Schattauer GmbH

Disseminierte intravasale Gerinnung (DIC) und Verbrauchskoagulopathie

Sepsis und Schock
P. Ostendorf
1   Medizinische Universitäts-Klinik, Abt. II (Direktor: Prof. Dr. H. D. Waller), Tübingen
,
K. Jaschonek
1   Medizinische Universitäts-Klinik, Abt. II (Direktor: Prof. Dr. H. D. Waller), Tübingen
,
W. Daiß
1   Medizinische Universitäts-Klinik, Abt. II (Direktor: Prof. Dr. H. D. Waller), Tübingen
› Author Affiliations
Further Information

Publication History

Publication Date:
22 June 2018 (online)

Also available at
    Permissions and Reprints

Zusammenfassung

Die Vorstellung zur Pathogenese der disseminierten intravasalen Gerinnung, die Beziehung zwischen Verbrauchskoagulopathie und disseminierter Thrombosierung der Mikrozirkulation und die resultierenden Symptomkomplexe von Blutung, Hyperfibrinolyse, Organschädigung, Hämolyse und Azidose sind in Abb. 7 als Zusammenfassung dieser Arbeit gegenübergestellt.

 

  • LITERATUR

  • 1 Nauyn B. Untersuchungen über Blutgerinnung I. M. lebender Tiere und ihre Folgen. Arch. Exp. Pathol. Pharmak. 01: 1 1873;
    PubMedGoogle Scholar
  • 2 Foä P, Pellacani P. Sul fermento fibrinogeno. Sülle azioni tossiche, exercitate da alcuni organi freschi. Arch. Sci. Med. 07: 113 1884;
    PubMedGoogle Scholar
  • 3 Lasch H. G, Krecke H-J, Rodriguez-Erdmann F, Sessner H. H, Schütterle G. Verbrauchskoagulopathien (Pathogenese und Therapie). Folia haematologica N. F. 06: 325-330 1961;
    PubMedGoogle Scholar
  • 4 McKay D. G. Disseminated intravascular coagulation. Harper & Row; New York: 1965
    Google Scholar
  • 5 Hardaway R. M. Syndromes of disseminated intravascular coagulation. With Special Reference to Shock and Hemorrhage. Thomas, Springfield: 1966
    Google Scholar
  • 6 Müller-Berghaus G. Aktivierung der Blutgerinnung bei Sepsis durch gram-negative Bakterien. In: Deutsch E, Lechner K. (Hrsg.): Fibrinolyse, Thrombose, Hämostase. Schattauer, Stuttgart; New York: 1980. 166 ff.
    Google Scholar
  • 7 Colman R. W. Surface-mediated defense reactions. The Plasma Contact Activation System. J. Clin. Invest. 73: 1249-1253 1984;
    CrossrefPubMedGoogle Scholar
  • 8 Niewiarowski S, Stuart R. K, Thomas D. P. Activation of intravascular coagulation by collagen. Proc. Soc. Exp. Biol. Med. 123: 196 1966;
    CrossrefPubMedGoogle Scholar
  • 9 Wilner G. D, Nossel H. L, Le Roy E. D. Activation of Hageman factor by collagen. J. Clin. Invest. 47: 2608-2615 1968;
    CrossrefPubMedGoogle Scholar
  • 10 Morrison D. C, Cochrone C. G. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins). J. Exp. Med. 140: 797 1974;
    CrossrefPubMedGoogle Scholar
  • 11 Mason J. W, Colman R. W. The role of Hageman factor in disseminated intravascular coagulation induced by septicemia, neoplasia or liver disease. Thromb. Diath. Haemorrh. 26: 325-331 1971;
    PubMedGoogle Scholar
  • 12 Mason J. W, Kleeberg U, Dolan P, Colman R. W. Plasma kallikrein and Hageman factor in gram-negative bacteremia. Ann. Int. Med. 73: 545-551 1970;
    CrossrefPubMedGoogle Scholar
  • 13 Heinrich D. Sepsis und Blutgerinnung (Sepsis aus der Sicht des Hämostaseologen). Beitr. Infusionstherapie klin. Ernähr. 10: 25-41 1983;
    PubMedGoogle Scholar
  • 14 Gurewich V, Nunn T, Lipinski B. Activation of intrinsic or extrinsic blood coagulation in experimental venous thrombosis and disseminated intravascular coagulation: Pathogenetic differences. Thromb. Res. 14: 931-940 1979;
    CrossrefPubMedGoogle Scholar
  • 15 Radcliffe R, Nemerson Y. Mechanism of activation of bovine factor VII. Products of cleavage by factor Xa. J. Biol. Chem. 251: 4797-4800 1976;
    PubMedGoogle Scholar
  • 16 Radcliffe R, Bagdasarian A, Colman R, Nemerson Y. Activation of bovine factor VII by Hageman factor fragments. Blood 50: 611-617 1977;
    PubMedGoogle Scholar
  • 17 Nemerson Y. Regulation of the initiation of coagulation by factor VII. Haemostasis 13: 150-155 1983;
    PubMedGoogle Scholar
  • 18 Osterud B. Activation pathways of the coagulation system in normal haemostasis. Scand. J. Haematol 32: 337-345 1984;
    PubMedGoogle Scholar
  • 19 Maynard J. R, Dreyer B. G, Stemerman M. E, Pitlick F. A. Tissue-factor coagulant activity of cultured human endothelial and smooth muscle cells and fibroblasts. Blood 50: 387-396 1977;
    PubMedGoogle Scholar
  • 20 Gralnick H. R, Abrell E. Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukaemia. Brit. J. Haematol. 24: 89 1973;
    CrossrefPubMedGoogle Scholar
  • 21 Pineo G. F, Regoeczi E, Hatton M. W. C, Brain M. C. The activation of coagulation by extracts of mucus: a possible pathway of intravascular coagulation accompanying adenocarcinomas. J. Lab. Clin. Med. 82: 255-266 1973;
    PubMedGoogle Scholar
  • 22 Gordon S. G, Franks J. J, Lewis B. Cancer procoagulant A: A factor X activating procoagulant from malignant tissue. Thromb. Res. 06: 127-137 1975;
    CrossrefPubMedGoogle Scholar
  • 23 Ostendorf P. Pathogenese venöser Thrombosen. In: Tscherne H, Deutsch E. (Hrsg.): Postoperative Thromboembolie-Prophylaxe aus aktueller Sicht. Thieme, Stuttgart; New York: 1981: 18-31.
    Google Scholar
  • 24 Osterud B, Rapaport S. I. Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc. Natl. Acad. Sci. 74: 5260-5264 1977;
    CrossrefPubMedGoogle Scholar
  • 25 Franza B. R, Aronson D. L, Finlayson J. B. Activation of human prothrombin by procoagulant factor from the venom of echis carinatus. J. Biol. Chem. 250: 7057 1975;
    PubMedGoogle Scholar
  • 26 Weiss H. J, Allan S, Davidson E, Kochwa S. Afibrinogenemia in man following the bite of a rattlesnake (crotalus adamanteus). Amer. J. Med. 47: 625-634 1969;
    CrossrefPubMedGoogle Scholar
  • 27 Ostendorf P. Klinische und experimentelle Untersuchungen zur Pathogenese der Schocklunge. Habilitationsschrift, Tübingen: 1977
    Google Scholar
  • 28 Brox J. H, Osterud B, Bjorklid E, Fenton J. W. Production and availability of thromboplastin in endothelial cells: the effects of thrombin, endotoxin and platelets. Brit. J. Haematol. 57: 239-246 1984;
    CrossrefPubMedGoogle Scholar
  • 29 Niemetz J. Coagulant activity of leukocytes: Tissue factor activity. J. Clin. Invest. 51: 307-313 1972;
    CrossrefPubMedGoogle Scholar
  • 30 Muhlfelder T. W, Khan I, Niemetz J. Factors influencing the release of procoagulant-tissue factor activity from leucocytes. J. Lab. Clin. Med. 92: 65-72 1978;
    PubMedGoogle Scholar
  • 31 Miiller-Berghaus G, Bohn E, Höbel W. Activation of intravascular coagulation by endotoxin: the significance of granulocyte and platelets. Brit. J. Haematol. 33: 213-220 1976;
    CrossrefPubMedGoogle Scholar
  • 32 Lipinski B, Gurewich V. The effect of leukopenia versus thrombocytopenia on endotoxin induced intravascular coagulation. Thromb. Res. 08: 403-411 1976;
    CrossrefPubMedGoogle Scholar
  • 33 Rivers R. P. A, Hathaway W. E, Weston W. L. The endotoxin-induced coagulant activity of human monocytes. Brit. J. Haemat. 30: 311-316 1975;
    CrossrefPubMedGoogle Scholar
  • 34 Hiller E, Saal J. G, Ostendorf P, Griffiths J. W. The procoagulant activity of human granulocytes, lymphocytes and monocytes stimulated by endotoxin. Klin. Wschr. 55: 751-757 1977;
    CrossrefPubMedGoogle Scholar
  • 35 Van Ginkel C. J. W, Zeiglemaker W. P, Strieker L. A. M. Enhancement of monocyte thromboplastin activity by antigenically stimulated lymphocytes: A link between immune reactivity and blood coagulation. Eur. J. Immunol. 11: 579-583 1981;
    CrossrefPubMedGoogle Scholar
  • 36 Levy G. A, Schwartz B. S, Edgington T. S. The existence of T helper (Tì) and T suppressor (Tã) cells for the generation of monocyte thromboplastin activity by lipopolysaccharides. Thromb. Haemostasis. 46: 302 1981; Abstr. 0945.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 37 Carson S. D. Tissue factor-initiated blood coagulation. Progr. in Clin. Pathol. 09: 1-14 1984;
    PubMedGoogle Scholar
  • 38 Osterud B, Flaegstad T. Increased tissue thromboplastin activity in monocytes of patients with meningococcal infection: Related to an unfavourable prognosis. Thromb. Haemost. 49: 5-7 1983;
    Article in Thieme ConnectPubMedGoogle Scholar
  • 39 Ostendorf P, Mittermayer C. hr. Bedeutung der Mikroembolien für die Entstehung der Schocklunge. In: Marx R, Thies H. A. Lunge, Blutgerinnung und Hämostase. Editiones Roche, Basel; 1981: 175-186.
    Google Scholar
  • 40 Abraham E, Bland R. D, Cobo J. C, Shoemaker W. C. Sequential cardiorespiratory patterns associated with outcome in septic shock. Chest. 85: 75-80 1984;
    CrossrefPubMedGoogle Scholar
  • 41 Brigham K. L, Begley C. J, Bernard G. R, Hutchinson A. A, Loyd J. E, Lucht W. D, Meyrick B, Newman J. H, Niedermeyer M. E, Ogletree M. L, Sheller J. R, Snapper J. R. Septicemia and lung injury. Clin. Labor. Med. 03: 719-744 1983;
    PubMedGoogle Scholar
  • 42 Cooper J. A, Solano S. J, Bizios R, Kaplan J. E, Malik A. B. Pulmonary neutrophil kinetics after thrombin-induced intravascular coagulation. J. Appl. Physiol.: Respirat. Environ. Exer. Physiol. 57: 826-832 1984;
    PubMedGoogle Scholar
  • 43 Heflin A. C, Brigham K. L. Prevention by granulocyte depletion of increased vascular permeability of sheep lung following endotoxemia. J. Clin. Invest. 68: 1253-1260 1981;
    CrossrefPubMedGoogle Scholar
  • 44 Kramer W, Müller-Berghaus G. Effect of platelet antiserum on the activation of intravascular coagulation by endotoxin. Thromb. Res. 10: 47-70 1977;
    CrossrefPubMedGoogle Scholar
  • 45 George J. N, Nurden A. T, Phillips D. R. Molecular defects in interactions of platelets with the vessel wall. New Engl. J. Med. 311: 1084-1098 1984;
    CrossrefPubMedGoogle Scholar
  • 46 Lüscher E. F. The role of blood cells and of the vessel wall in the induction of intravascular coagulation. Klin, Wschr. 60: 710-712 1982;
    CrossrefPubMedGoogle Scholar
  • 47 Carmona R. H, Tsao T. C, Trunkey D. D. The role of prostacyclin and thromboxane in sepsis and septic shock. Arch. Surg. 119: 189-192 1984;
    CrossrefPubMedGoogle Scholar
  • 48 Ditter H, Matthias F. R, Reitz D. Auswirkungen einer Infusion von Prostazyklin (PGI2) auf die Plättchenzahl und den Prostaglandinstoffwechsel der Plättchen während des experimentellen Endotoxinschocks. Verh. Dtsch. Ges. Inn. Med. 89: 1120-1124 1983;
    PubMedGoogle Scholar
  • 49 Fletcher J. R. Prostaglandin-SynthetaseInhibitors in Endotoxin or Septic Shock A Review. Adv. Shock Res. 10: 9-14 1983;
    PubMedGoogle Scholar
  • 50 Reines H. D, Halushka P. V, Cook J. A, Wise W. C, Rambo W. Plasma thromboxane concentrations are raised in patients dying with septic shock. Lancet. II: 174-175 1982;
    PubMedGoogle Scholar
  • 51 Webb P. J, Westwick J, Scully M. F, Zahavi J, Kakkar V. V. Do prostacyclin and thromboxane play a role in endotoxic shock? Brit. J. Surg. 68: 720-724 1981;
    CrossrefPubMedGoogle Scholar
  • 52 Miiller-Berghaus G, Lohmann E. The role of complement in endotoxin-induced disseminated intravascular coagulation: studies in congenitally C6-deficient rabbits. Brit. J. Haemat. 28: 403 1974;
    CrossrefPubMedGoogle Scholar
  • 53 Osterud B, Eskeland T. The mandatory role of complement in the endotoxininduced synthesis of tissue thromboplastin in blood monocytes. FEBS Letts. 149: 75-79 1982;
    CrossrefPubMedGoogle Scholar
  • 54 Ostendorf P, Freund M. Pneumokokkenvakzine nach Splenektomie? Zur Pathogenese und Prophylaxe der OPSI (Overwhelming Post-Splenectomy-Infection). Internist. 22: 171-174 1981;
    PubMedGoogle Scholar
  • 55 Mosher D. F, Williams E. M. Fibronectin concentration is decreased in plasma of severely ill patients with disseminated intravascular coagulation. J. Lab. Clin. Med. 91: 729-735 1978;
    PubMedGoogle Scholar
  • 56 McKay D. G, Müller-Berghaus G. Therapeutic implications of disseminated intravascular coagulation. Amer. J. Cardiol. 20: 392-410 1967;
    CrossrefPubMedGoogle Scholar
  • 57 Nossel H. L, Wasser J, Kaplan K. L. et al. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline. J. Clin. Invest. 64: 1371-1378 1979;
    CrossrefPubMedGoogle Scholar
  • 58 Freund M, Ostendorf P, Gärtner V. H, Tidow S. OPSI - Ein Fall foudroyant verlaufender Sepsis. Internist. 22: 175-179 1981;
    PubMedGoogle Scholar
  • 59 Freund M, Ostendorf P, Hiller E. Ein Fall von Clostridienbakteriämie mit Verbrauchskoagulopathie. Internist. 22: 514-517 1981;
    PubMedGoogle Scholar
  • 60 Kirchner C. W, Reheis C. E. Two serious complications of neoplasia: Sepsis and disseminated intravascular coagulation. Nursing Clinics of North America. 17: 595-606 1982;
    PubMedGoogle Scholar
  • 61 Edwards R. L, Rickles F. R, Cronlund M. Abnormalities of blood coagulation in patients with cancer. Mononuclear cell tissue factor generation. J. Lab. Clin. Med. 98: 917-928 1981;
    PubMedGoogle Scholar
  • 62 Romero R, Duffy T. P, Berkowitz R. L, Chang E, Hobbins J. C. Prolongation of a preterm pregnancy complicated by death of a single twin in utero and disseminated intravascular coagulation. Effects of treatment with heparin. New Engl. J. Med. 310: 772-774 1984;
    CrossrefPubMedGoogle Scholar
  • 63 Müller-Berghaus G, Lasch H-G. Microcirculatory disturbances induced by generalized intravascular coagulation. In: Handbook of Experimental Pharmacology XVI/3. Springer, Berlin, Heidelberg; New York: 1975: 429-514.
    Google Scholar
  • 64 Tate R. M, Repine J. E. Neutrophils and the adult respiratory distress syndrome. Amer. Rev. Resp. Dis. 128: 552-559 1983;
    PubMedGoogle Scholar
  • 65 Staub N. C, Schultz E. L, Albertine K. H. Leucocytes and pulmonary microvascular injury. Ann. N. Y. Acad. Sci. 384: 332-342 1982;
    CrossrefPubMedGoogle Scholar
  • 66 Malik A. B, Johnson A, Tahamont M. V. Mechanisms of lung vascular injury after intravascular coagulation. Ann. N. Y. Acad. Sci. 384: 213-234 1982;
    CrossrefPubMedGoogle Scholar
  • 67 v. Tahamont M, Malik A. B. Granulocytes mediate the increase in pulmonary vascular permeability after thrombin embolism. J. Appl. Physiol.: Respirat. Environ. Exercise Physiol. 54: 1489-1495 1983;
    PubMedGoogle Scholar
  • 68 Ostendorf P, Birzle H, Vogel W, Mittermayer C. h. Pulmonary radiographic abnormalities in shock. Roentgenclinical pathological correlation. Radiology 115: 257-263 1975;
    CrossrefPubMedGoogle Scholar
  • 69 Heene D. L, Kirchstein W. Nachweis von Fibrinderivaten im Plasma bei Sepsis. In: Deutsch E, Lechner K. (Hrsg.): Fibrinolyse, Thrombose, Hämostase. Schattauer, Stuttgart; New York: 1980: 169-174.
    Google Scholar
  • 70 Heene D. L, Lasch H. G, Matthias F. R. Gerinnungsstörungen und Verbrauchskoagulopathie bei polytraumatisierten Patienten. Intensivbehandlung 01: 42-48 1976;
    PubMedGoogle Scholar
  • 71 Thaler E. Verhalten der Inhibitoren der Blutgerinnung und Fibrinolyse bei Sepsis. In: Deutsch E, Lechner K. (Hrsg.): Fibrinolyse, Thrombose, Hämostase. Schattauer, Stuttgart; New York: 1980. 179ff.
    Google Scholar
  • 72 Lämmle B, Tran T. H, Ritz R, Duckert F. Plasma prekallikrein, factor XII, antithrombin III, C− 1-inhibitor and á2-macroglobulin in critically III patients with suspected disseminated intravascular coagulation (DIC). Amer. J. Clin. Pathol. 82: 396-404 1984;
    PubMedGoogle Scholar
  • 73 Gardiner J. E, Griffin J. H. Human protein C and thromboembolic disease. Progr. Hematol 12: 265-278 1981;
    PubMedGoogle Scholar
  • 74 Bick L, Dukes M. L, Wilson W. L, Fekete L. F. Antithrombin III (AT-III) as a diagnostic aid in disseminated intravascular coagulation. Thrombosis Res. 10: 721-729 1977;
    CrossrefPubMedGoogle Scholar